SHIPPEO
7.12.2022 11:55:36 CET | Business Wire | Press release
Shippeo, a leading provider of global and multimodal shipment visibility, announced major platform enhancements as part of their feature-packed 2022 Autumn platform release at their Visibility Now! event in Paris. The update brings a range of new, disruptive capabilities to their Ocean Visibility solution, higher accuracy carbon emissions calculations powered by specialist Searoutes, and a range of general enhancements aimed at boosting data quality, usability and supply chain ecosystem collaboration.
“We know that supply chain resiliency is top of mind for supply chain executives and that dynamic operational visibility is foundational for resilience,” explains Anand Medepalli, Chief Product Officer at Shippeo. “Our latest platform release brings a range of exciting features and capabilities, arming organizations with the tools and knowledge to make quicker decisions, mitigate disruptions and collaborate with trading partners in real time, so that supply chain actors can design, plan and run the most profitable, sustainable and resilient supply chains.”
“The enormous challenges and uncertainty around ocean shipping, and growing internal and external pressures for businesses to operate more sustainably, are key drivers for the exciting innovations we’re introducing in our Autumn release, delivering significant value for our customers. We know that Shippeo’s value comes from us being a reliable visibility platform with a strong carrier network delivering high quality visibility data and meaningful insights with an intuitive user experience. These are precisely the areas our product team focused on in 2022.”
Major enhancements to Ocean Visibility platform including a new Port Insights engine
Shippeo’s latest Ocean Visibility solution updates provide customers with more useful, higher-quality ocean transport data, thanks to a new tech architecture supporting data quality and scalability improvements, making it possible to track an unlimited number of containers across multiple data sources. In addition, new dashboards provide powerful insights to aid in contract negotiations with carriers.
Enhanced demurrage and detention analytics down to a port pair level make it easier to identify and proactively react to affected containers. New Lane Insights highlight lead time, punctuality, transshipment duration, and more, offering new network analysis tools for shippers. Shippers can identify weak spots, such as ports or carriers experiencing frequent delays, and access lane analysis for specific routes.
Port Insights provides shippers with a better understanding of congestion and efficiency at ports throughout the world. In addition, by drawing on Shippeo’s multi-year research into ETA algorithms and geofencing technology, users benefit from best-in-class vessel ETAs, promising significant accuracy improvements over those provided by shipping lines. Through combining historical data with live AIS satellite data, terrestrial data and vessel schedule data, Shippeo’s Port Insights engine generates more accurate arrival and departure events at marine ports, resulting in the highest fidelity visibility of journeys and milestones for any shipment.
“We believe our Ocean Visibility platform offers the most accurate view available of what’s happening for any port on the planet,” says Medepalli. “With insights on more than 3000 ports worldwide, we offer customers a more complete and accurate understanding of their vessel routes. Along with our enhanced Demurrage and Detention dashboard, Lane Insights and best-in-class vessel ETA algorithm, our latest ocean product update is a disruptive, market-leading solution. And, as it is built on the same platform as our Road, Air and Rail Visibility solutions, we can help track multimodal shipments, regardless of which modes are used.”
New Searoutes partnership for reliable, global CO2 emission calculations
Shippeo’s Carbon Visibility product takes granular shipment level data, including routes, mileage, and more, to estimate carbon emissions attributable to road, ocean, inland waterway, rail and air shipments. A new platform integration with specialist carbon emissions estimating company Searoutes now allows accredited, higher quality carbon, and other greenhouse gas-equivalent emissions calculations across all transport modes in a single platform.
Searoutes also offers the unique benefit of modeled calculations for both milk-runs over road, and for ocean shipments. Advanced algorithms and a more detailed analysis, mean emissions are now less likely to be overstated and insights are more actionable.
“By combining Shippeo’s high quality data and Searoutes’s state-of-the-art models, our platform offers a unique and powerful Carbon Visibility solution to help our customers run sustainable supply chains,” explains Medepalli. “Our approach to carbon reporting simplifies effort for shippers and carriers by combining analysis across all modes in a single platform, and makes it possible to review carbon footprint at different levels of granularity, such as by region or business unit.”
Searoutes CEO, Pierre Garreau, expresses his delight about the partnership. “Searoutes was founded to find ways to use the latest data modeling and AI to solve the dual challenge of lowering fuel consumption and carbon emissions in one of the biggest contributing sectors to climate change; transportation,” says Garreau. “Today, Shippeo offers the best visibility data stewardship out there, so the mix of their excellent data quality with top-notch greenhouse gas emissions modeling from Searoutes will give customers the ability to have extremely accurate emissions reporting to help figure out a baseline for determining the best supply chain strategy, as they navigate an increasingly regulated shipping landscape.”
Platform innovations boosting data quality, usability and supply chain ecosystem collaboration
Along with Ocean and Carbon Visibility solution enhancements, Shippeo has introduced a number of other platform updates to propel its category-leading data intelligence capabilities even further. It’s now easier to detect broken telematics units with Shippeo platform’s unique Smart Tracking Analyzer, a tool which analyzes root-causes of low tracking rates and prescribes actions for users to remedy them. In addition, it’s now possible for users to update transport orders and add milestone events, such as multiple delivery attempts, even after transportation has finished, so that recorded information can be made more accurate, contributing to overall quality of visibility data.
In parallel, a new Notifications Builder offers platform users the ability to fully configure, customize and white label notifications. With a simple UI, the tool introduces greater flexibility for new ways to communicate and collaborate with ecosystem partners.
Watch Shippeo’s full autumn platform release announcement
About Searoutes
Searoutes specializes in innovative digital solutions for sustainability within the sea, air and logistics sector. The company is rooted in its proprietary routing algorithms that use historical ship data collected from AIS signals that allow for greater accuracy through superior methodologies. Today, Searoutes has developed a comprehensive collection of APIs to search, report and plan on real-time routes and CO2 emissions for all modes of transport to facilitate the decarbonization of freight transport.
About Shippeo
Shippeo is a global leader in real-time multimodal transportation visibility, helping major shippers and logistics service providers operate more collaborative, automated, sustainable, profitable, and customer-centric supply chains. This is made possible with highly accurate, real-time operational visibility and perfect workflow orchestration. Their Multimodal Visibility Network integrates with more than 875 TMS, telematics and ELD systems, enabling Shippeo’s platform to provide instant access to real-time shipment tracking across all transport modes, in a single portal, through an intuitive user experience. A proprietary and industry-leading machine learning algorithm offers unmatched ETA accuracy, allowing supply chain companies to quickly anticipate problems, proactively alert customers, efficiently manage exceptions with collaborative workflows, and accurately measure CO2 and GHG emissions from supply chain transport. Hundreds of customers, including global brands like Coca-Cola HBC, Carrefour, Renault Group, Schneider Electric, Total, Siemens Energy, Faurecia, Saint-Gobain and Eckes Granini, trust Shippeo to track more than 28 million shipments per year across 95 countries. Learn more at www.shippeo.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221206005768/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
